These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors. Arosio D, Manzoni L, Corno C, Perego P. Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756 [Abstract] [Full Text] [Related]
11. Nanotherapy Targeting the Tumor Microenvironment. Gong BS, Wang R, Xu HX, Miao MY, Yao ZZ. Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855 [Abstract] [Full Text] [Related]
18. Integrins Within the Tumor Microenvironment: Biological Functions, Importance for Molecular Targeting, and Cancer Therapeutics Innovation. Dzobo K. OMICS; 2021 Jul; 25(7):417-430. PubMed ID: 34191612 [Abstract] [Full Text] [Related]
20. The complexity of integrins in cancer and new scopes for therapeutic targeting. Hamidi H, Pietilä M, Ivaska J. Br J Cancer; 2016 Oct 25; 115(9):1017-1023. PubMed ID: 27685444 [Abstract] [Full Text] [Related] Page: [Next] [New Search]